We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.05B
AUM Growth
-$157M
Cap. Flow
-$123M
Cap. Flow %
-11.81%
Top 10 Hldgs %
60.57%
Holding
47
New
9
Increased
9
Reduced
18
Closed
11

Top Buys

Rank Stock Value
1
TWST icon
Twist Bioscience
TWST
+$55.4M
2
IRTC icon
iRhythm Holdings
IRTC
+$33.8M
3
MDXG icon
MiMedx Group
MDXG
+$26M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$24.9M
5
VERA icon
Vera Therapeutics
VERA
+$24.6M

Top Sells

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$39.4M
2
PODD icon
Insulet
PODD
+$31.5M
3
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$31.5M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$24.8M
5
DYN icon
Dyne Therapeutics
DYN
+$24.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNA
1
DELISTED
Paragon 28, Inc.
FNA
$109M 10.46%
10,580,467
+425,824
+4% +$3.44M
CNTA
2
DELISTED
Centessa Pharmaceuticals
CNTA
$97.2M 9.3%
5,805,184
-134,948
-2% -$2.24M
AXGN icon
3
Axogen
AXGN
$2.27B
$74.3M 7.11%
4,506,795
+416,499
+10% +$5.9M
ATRC icon
4
AtriCure
ATRC
$1.92B
$60.2M 5.76%
1,969,221
+103,685
+6% +$3.33M
TWST icon
5
Twist Bioscience
TWST
$5.7B
$57M 5.45%
+1,226,255
New +$55.4M
VERA icon
6
Vera Therapeutics
VERA
$2.3B
$53.3M 5.1%
1,261,246
+556,012
+79% +$24.6M
NEO icon
7
NeoGenomics
NEO
$1.96B
$52.2M 4.99%
3,167,585
+91,030
+3% +$1.41M
XENE icon
8
Xenon Pharmaceuticals
XENE
$6.06B
$45.5M 4.35%
1,160,580
-21,082
-2% -$872K
CRNX icon
9
Crinetics Pharmaceuticals
CRNX
$8.84B
$45.3M 4.33%
885,453
-58,158
-6% -$3.25M
IRTC icon
10
iRhythm Holdings
IRTC
$3.85B
$38.8M 3.71%
+430,500
New +$33.8M
HCAT icon
11
Health Catalyst
HCAT
$154M
$37.1M 3.55%
5,241,121
+944,631
+22% +$7.52M
PHLT
12
DELISTED
Performant Healthcare Inc
PHLT
$34.3M 3.28%
11,346,649
+136,249
+1% +$468K
INSM icon
13
Insmed
INSM
$21.4B
$32.5M 3.11%
470,192
-218,718
-32% -$15.8M
MDXG icon
14
MiMedx Group
MDXG
$602M
$32.2M 3.08%
+3,343,861
New +$26M
RARE icon
15
Ultragenyx Pharmaceutical
RARE
$2.45B
$32.1M 3.07%
763,607
+8,505
+1% +$422K
KRMD icon
16
KORU Medical Systems
KRMD
$189M
$22.8M 2.18%
5,915,434
+316,509
+6% +$1.03M
PLRX icon
17
Pliant Therapeutics
PLRX
$64.4M
$22.1M 2.12%
1,681,110
-894,436
-35% -$12.2M
EWTX icon
18
Edgewise Therapeutics
EWTX
$4.13B
$20.8M 1.99%
+780,639
New +$24.9M
JANX icon
19
Janux Therapeutics
JANX
$925M
$16.8M 1.61%
+313,782
New +$16.6M
SIBN icon
20
SI-BONE Inc
SIBN
$788M
$15.9M 1.53%
1,136,982
-389,233
-26% -$5.24M
KYMR icon
21
Kymera Therapeutics
KYMR
$8.51B
$15.4M 1.48%
383,310
-23,038
-6% -$1.04M
NTRA icon
22
Natera
NTRA
$38.3B
$14.7M 1.41%
93,088
-91,851
-50% -$13.4M
BFLY icon
23
Butterfly Network
BFLY
$1.89B
$12.5M 1.19%
+3,994,620
New +$10.4M
RGEN icon
24
Repligen
RGEN
$7.96B
$11.9M 1.14%
82,455
-83,418
-50% -$12M
ANAB icon
25
AnaptysBio
ANAB
$1.58B
$11.5M 1.1%
868,882
-79,249
-8% -$1.92M
1
2

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, First Light Asset Management held 47 positions worth $1.05B, down 13% from $1.2B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

First Light Asset Management withdrew a net $123M in Q4 2024, closing 11 positions and reducing 18 holdings. Its most notable exit was Avid Bioservices, Inc. Common Stock, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

Against the trend, First Light Asset Management opened a new position in Twist Bioscience worth $57M.

  • First Light Asset Management's largest Q4 2024 buy was Twist Bioscience: 1,226,255 shares worth $57M.
  • First Light Asset Management added most to Vera Therapeutics in Q4 2024, an estimated $24.6M increase.
  • First Light Asset Management's biggest Q4 2024 reduction was Evolent Health, cutting an estimated $39.4M.
  • First Light Asset Management fully exited Avid Bioservices, Inc. Common Stock in Q4 2024, selling an estimated $31.5M.
  • First Light Asset Management's ten largest holdings make up 61% of its $1.05B portfolio in Q4 2024.
  • First Light Asset Management opened 9 new positions and closed 11 in Q4 2024.
  • First Light Asset Management's portfolio value fell 13% quarter-over-quarter to $1.05B.

Based on First Light Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.